Document is current
Any future updates will be listed below
-
Authors
Saeed, Kordo https://orcid.org/0000-0003-0123-0302
Ahmad-Saeed, Nusreen
Annett, Rachel
Barlow, Gavin
Barrett, Lucinda
Boyd, Sara E.
Boran, Nicola
Davies, Peter
Hughes, Harriet
Jones, Gwennan
Leach, Laura
Lynch, Maureen
Nayar, Deepa
Maloney, Robert J.
Marsh, Martin
Milburn, Olivia
Mitchell, Shanine
Moffat, Lynn
Moore, Luke S. P.
Murphy, Michael E.
O’Shea, Shaan Ashk
O’Sullivan, Fionnuala
Peach, Teresa
Petridou, Christina
Reidy, Niamh
Selvaratnam, Mathyruban
Talbot, Ben
Taylor, Vanessa
Wearmouth, Deborah
Aldridge, Catherine
-
Funding
Funding for this research was provided by:
bioMérieux
- License Information
-
More Information
Article History
Received: 27 September 2022
Accepted: 28 November 2022
First Online: 7 December 2022
Declarations
:
: All sites obtained individual approval via their research ethics and/or governance boards and recorded the study a service evaluation project or registered it as a quality improvement project. All data was collected and stored in accordance with the Data Protection Act and the General Data Protection Regulation (GDPR) and anonymised prior to sharing with the wider joint infection study team.
: Not sought as service evaluation and anonymised data.
: Not sought as service evaluation and anonymised data.
: KS has received research grants and speaker fees from Pfizer, Thermo Fisher, and Menarini. LSPM has consulted for and received speaker fees from bioMerieux, Pfizer, Eumedica, Shionogi, Pulmocide, Umovis Labs, DNA Electronics, Kent Pharma, and Sumitovant and received research grants from the UK National Institute for Health Research (NIHR), LifeArc, and the CW + charity. SEB held research funding through an MRC RCUK/UKRI Innovation Fellowship (MR/R016895/1) and the North West MRC Scheme in Clinical Pharmacology (MR/N025989/1). She received research support from Roche Pharma and has consulted for/received speaker fees from Sumitovant and Shionogi. CA received speaker fees from bioMerieux.
